Literature DB >> 1954216

Synergism between diabetic and radiation retinopathy: case report and review.

M Viebahn1, M E Barricks, M D Osterloh.   

Abstract

It is suspected that radiation retinopathy is more likely to develop in an eye with preexisting diabetic retinopathy than in a normal eye. However, there is only one report of this occurring, at a radiation dose of 4500 rads. We present a woman with minimal diabetic retinopathy who had breast carcinoma which was treated with chemotherapy but metastasised to the choroid. Within nine months of external beam radiation (3000 rads in fractions of 200 rads) a fulminant retinopathy evolved in that eye, while the non-radiated eye showed no change. The histopathology of radiation and diabetic retinopathy and causes for possible synergism are discussed. As this case report shows, radiation oncologists and ophthalmologists need to be aware of the risk that patients with minimal diabetic retinopathy who have undergone chemotherapy may suffer a dramatic visual loss from radiation therapy despite a radiation dose which is considered adequate, safe, and properly fractionated.

Entities:  

Mesh:

Year:  1991        PMID: 1954216      PMCID: PMC1042504          DOI: 10.1136/bjo.75.10.629

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  Electron microscopy of normal and diabetic retinal capillaries.

Authors:  D TOUSSAINT; P DUSTIN
Journal:  Arch Ophthalmol       Date:  1963-07

2.  Complications of cobalt plaque therapy of choroidal malanomas.

Authors:  D H Char; L I Lonn; L W Margolis
Journal:  Am J Ophthalmol       Date:  1977-10       Impact factor: 5.258

3.  Post-radiation retinopathy. A fluorescence fundus angiographic study.

Authors:  S S Hayreh
Journal:  Br J Ophthalmol       Date:  1970-11       Impact factor: 4.638

4.  Radiation retinopathy.

Authors:  W M Wara; A R Irvine; R E Neger; E L Howes; T L Phillips
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-01       Impact factor: 7.038

5.  Radiation retinopathy: an experimental model for the ischemic--proliferative retinopathies.

Authors:  A R Irvine; J A Alvarado; W M Wara; B W Morris; I S Wood
Journal:  Trans Am Ophthalmol Soc       Date:  1981

6.  Radiation retinopathy after irradiation of intracranial lesions.

Authors:  S M Bagan; R W Hollenhorst
Journal:  Am J Ophthalmol       Date:  1979-10       Impact factor: 5.258

7.  Effects of irradiation on the eye.

Authors:  R C Chan; L J Shukovsky
Journal:  Radiology       Date:  1976-09       Impact factor: 11.105

8.  Studies on diabetic retinopathy. 3. Influence of diabetes on intramural pericytes.

Authors:  P Speiser; A M Gittelsohn; A Patz
Journal:  Arch Ophthalmol       Date:  1968-09

9.  Posterior ocular abnormalities after irradiation for retinoblastoma: a histopathological study.

Authors:  P R Egbert; L F Fajardo; S S Donaldson; K Moazed
Journal:  Br J Ophthalmol       Date:  1980-09       Impact factor: 4.638

10.  Considerations in the diagnosis of radiation injury.

Authors:  D C Chacko
Journal:  JAMA       Date:  1981-03-27       Impact factor: 56.272

View more
  17 in total

Review 1.  Does radiotherapy have a role in the management of thyroid orbitopathy? View 1.

Authors:  Kimberley P Cockerham; John S Kennerdell
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  Ophthaproblem. Radiation retinopathy.

Authors:  Shaun Segal; Sanjay Sharma
Journal:  Can Fam Physician       Date:  2006-02       Impact factor: 3.275

3.  Long-term visual acuity results of treated and untreated radiation retinopathy (an AOS thesis).

Authors:  James L Kinyoun
Journal:  Trans Am Ophthalmol Soc       Date:  2008

4.  [Vitreous hemorrhage of unusual genesis].

Authors:  M Lukashevich; C Mayer
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

Review 5.  Advances in the management of thyroid eye diseases: An overview.

Authors:  Rashmi Kumari; Bhawesh Chandra Saha
Journal:  Int Ophthalmol       Date:  2017-08-18       Impact factor: 2.031

6.  Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.

Authors:  M D de Smet; V S Vancs; D Kohler; D Solomon; C C Chan
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

Review 7.  Intracranial long-term complications of radiation therapy: an image-based review.

Authors:  Carrie M Carr; John C Benson; David R DeLone; Felix E Diehn; Dong Kun Kim; Kenneth W Merrell; Alex A Nagelschneider; Ajay A Madhavan; Derek R Johnson
Journal:  Neuroradiology       Date:  2021-01-04       Impact factor: 2.804

8.  Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.

Authors:  Aline I Riechardt; Daniel Pilger; Dino Cordini; Ira Seibel; Enken Gundlach; Annette Hager; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-18       Impact factor: 3.117

9.  Medical management of thyroid eye disease.

Authors:  Dawn D Yang; Mithra O Gonzalez; Vikram D Durairaj
Journal:  Saudi J Ophthalmol       Date:  2010-10-26

10.  I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS Report No. 30.

Authors:  H Culver Boldt; B Michele Melia; Judy C Liu; Sandra M Reynolds
Journal:  Ophthalmology       Date:  2009-01       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.